Prestige Consumer Healthcare Inc (PBH)

Name: Prestige Consumer Healthcare Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Distribution

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$283M

Net Income

$46.7M

Operating Margin

29.1%

Free Cash Flow

$243M

Debt / Assets

46.1%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Prestige Consumer Healthcare Inc (PBH).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	283,444,000	274,114,000	249,530,000	296,755,000
Cost of Revenue	126,075,000	120,043,000	114,381,000	121,044,000
Gross Profit	157,369,000	154,071,000	135,149,000	175,711,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	69,729,000	66,738,000	63,393,000	64,054,000
Operating Expenses	74,878,000	74,401,000	63,393,000	87,283,000
Operating Income	82,491,000	79,670,000	71,756,000	88,428,000
Interest Expense	10,672,000	10,036,000	10,203,000	10,759,000
Income Before Tax	61,814,000	69,133,000	61,777,000	73,959,000
Income Tax Expense	15,118,000	26,922,000	14,311,000	23,831,000
Net Income	46,696,000	42,211,000	47,466,000	50,128,000
Per Share
EPS	0.98	0.86	0.96	1.01
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Prestige Consumer Healthcare Inc (PBH).
Income Statement (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Revenue	1,137,762,000	1,125,357,000	1,127,725,000	1,086,812,000	943,365,000
Cost of Revenue	503,299,000	500,909,000	502,431,000	466,166,000	395,893,000
Gross Profit	634,463,000	624,448,000	625,294,000	620,646,000	547,472,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	263,932,000	259,467,000	252,415,000	265,859,000	226,129,000
Operating Expenses	297,688,000	282,019,000	277,492,000	290,727,000	250,070,000
Operating Income	336,775,000	342,429,000	345,466,000	329,919,000	297,402,000
Interest Expense	47,632,000	67,160,000	69,164,000	64,287,000	82,328,000
Income Before Tax	284,189,000	276,025,000	-93,915,000	262,458,000	204,113,000
Income Tax Expense	69,584,000	66,686,000	-11,609,000	57,077,000	39,431,000
Net Income	214,605,000	209,339,000	-82,306,000	205,381,000	164,682,000
Per Share
EPS	4.32	4.21	-1.65	4.09	3.28
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Prestige Consumer Healthcare Inc (PBH).
Balance Sheet (Quarterly)	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Assets
Cash and Cash Equivalents	97,884,000	46,469,000	58,489,000	27,185,000
Short Term Investments	0	0	0	0
Net Receivables	194,293,000	176,775,000	167,016,000	139,330,000
Inventory	147,709,000	138,717,000	162,121,000	120,342,000
Total Current Assets	448,328,000	375,043,000	391,743,000	293,267,000
Property Plant Equipment	127,842,000	89,333,000	89,535,000	98,530,000
Goodwill and Intangibles	2,822,775,000	2,848,316,000	2,869,446,000	3,275,611,000
Total Assets	3,402,218,000	3,318,417,000	3,353,729,000	3,670,681,000
Liabilities
Account Payables	18,925,000	38,979,000	62,743,000	55,760,000
Short Term Debt	8,537,000	6,152,000	19,520,000	9,112,000
Total Current Liabilities	106,623,000	117,048,000	160,715,000	143,422,000
Long Term Debt	1,035,713,000	1,133,504,000	1,357,331,000	1,497,247,000
Total Liabilities	1,567,321,000	1,663,333,000	1,906,645,000	2,093,070,000
Shareholders Equity
Retained Earnings	1,555,802,000	1,341,197,000	1,131,858,000	1,214,164,000
Total Shareholders Equity	1,834,897,000	1,655,084,000	1,447,084,000	1,577,611,000

Balance sheet annual history for Prestige Consumer Healthcare Inc (PBH).
Balance Sheet (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Assets
Cash and Cash Equivalents	97,884,000	46,469,000	58,489,000	27,185,000	32,302,000
Short Term Investments	0	0	0	0	0
Net Receivables	194,293,000	176,775,000	167,016,000	139,330,000	114,671,000
Inventory	147,709,000	138,717,000	162,121,000	120,342,000	114,959,000
Total Current Assets	448,328,000	375,043,000	391,743,000	293,267,000	269,835,000
Property Plant Equipment	127,842,000	89,333,000	89,535,000	98,530,000	102,767,000
Goodwill and Intangibles	2,822,775,000	2,848,316,000	2,869,446,000	3,275,611,000	3,053,808,000
Total Assets	3,402,218,000	3,318,417,000	3,353,729,000	3,670,681,000	3,429,273,000
Liabilities
Account Payables	18,925,000	38,979,000	62,743,000	55,760,000	45,978,000
Short Term Debt	8,537,000	6,152,000	19,520,000	9,112,000	8,446,000
Total Current Liabilities	106,623,000	117,048,000	160,715,000	143,422,000	122,138,000
Long Term Debt	1,035,713,000	1,133,504,000	1,357,331,000	1,497,247,000	1,506,175,000
Total Liabilities	1,567,321,000	1,663,333,000	1,906,645,000	2,093,070,000	2,070,975,000
Shareholders Equity
Retained Earnings	1,555,802,000	1,341,197,000	1,131,858,000	1,214,164,000	1,008,783,000
Total Shareholders Equity	1,834,897,000	1,655,084,000	1,447,084,000	1,577,611,000	1,358,298,000

Cash flow quarterly history for Prestige Consumer Healthcare Inc (PBH).
Cash Flow Statement (Quarterly)	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Operating Activities
Net Income	214,605,000	209,339,000	-82,306,000	205,381,000
Depreciation & Amortization	30,173,000	30,675,000	32,625,000	32,092,000
Stock Based Compensation	11,157,000	14,010,000	12,405,000	9,039,000
Change in Working Capital	-41,941,000	-39,831,000	-53,855,000	-10,946,000
Operating Cash Flow	251,515,000	248,926,000	229,716,000	259,922,000
Investing Activities
Capital Expenditure	-8,224,000	-9,550,000	-7,784,000	-9,642,000
Investments	-8,224,000	-9,550,000	-7,784,000	-9,642,000
Investing Cash Flow	-17,452,000	-20,111,000	-11,584,000	-256,511,000
Financing Activities
Debt Repayment	-139,536,000	-227,827,000	-157,752,000	-687,582,000
Common Stock Issued/Repurchased	-36,707,000	-25,000,000	-42,628,000	4,124,000
Dividends Paid	0	0	0	-4,124,000
Financing Cash Flow	-182,075,000	-241,015,000	-185,846,000	-7,569,000
Summary
Free Cash Flow	243,291,000	239,376,000	221,932,000	250,280,000
Net Change in Cash	51,415,000	-12,020,000	31,304,000	-5,117,000

Cash flow annual history for Prestige Consumer Healthcare Inc (PBH).
Cash Flow Statement (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Operating Activities
Net Income	214,605,000	209,339,000	-82,306,000	205,381,000	164,682,000
Depreciation & Amortization	30,173,000	30,675,000	32,625,000	32,092,000	30,164,000
Stock Based Compensation	11,157,000	14,010,000	12,405,000	9,039,000	8,543,000
Change in Working Capital	-41,941,000	-39,831,000	-53,855,000	-10,946,000	-5,598,000
Operating Cash Flow	251,515,000	248,926,000	229,716,000	259,922,000	235,607,000
Investing Activities
Capital Expenditure	-8,224,000	-9,550,000	-7,784,000	-9,642,000	-22,243,000
Investments	-8,224,000	-9,550,000	-7,784,000	-9,642,000	-22,243,000
Investing Cash Flow	-17,452,000	-20,111,000	-11,584,000	-256,511,000	-22,243,000
Financing Activities
Debt Repayment	-139,536,000	-227,827,000	-157,752,000	-687,582,000	-866,443,000
Common Stock Issued/Repurchased	-36,707,000	-25,000,000	-42,628,000	4,124,000	-11,867,000
Dividends Paid	0	0	0	-4,124,000	0
Financing Cash Flow	-182,075,000	-241,015,000	-185,846,000	-7,569,000	-279,419,000
Summary
Free Cash Flow	243,291,000	239,376,000	221,932,000	250,280,000	213,364,000
Net Change in Cash	51,415,000	-12,020,000	31,304,000	-5,117,000	-62,458,000